Donal O'Connor

Director, Perrigo Company Plc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 23, 2026Returned to company 6,009 shares of Theravance Biopharma, Inc.⁴
Sep 23, 2026Returned to company 74,204 shares of Theravance Biopharma, Inc.⁴
Jun 12, 2026Granted 6,009 shares of Theravance Biopharma, Inc.⁵
May 14, 2026Shares withheld for tax 3,507 shares at $10.84 of Perrigo Company Plc³
May 14, 2026Exercised options 7,305 shares at $10.84 of Perrigo Company Plc³
May 19, 2025Granted 10,649 shares of Theravance Biopharma, Inc.⁶
May 14, 2025Shares withheld for tax 4,754 shares at $26.01 of Perrigo Company Plc⁷
May 14, 2025Exercised options 9,904 shares at $26.01 of Perrigo Company Plc⁷
May 15, 2024Shares withheld for tax 4,207 shares at $30.22 of Perrigo Company Plc⁸
May 15, 2024Exercised options 8,764 shares at $30.22 of Perrigo Company Plc⁸
May 8, 2024Granted 10,537 shares of Theravance Biopharma, Inc.⁹
May 17, 2023Shares withheld for tax 3,734 shares at $32.86 of Perrigo Company Plc¹⁰
May 17, 2023Exercised options 7,778 shares at $32.86 of Perrigo Company Plc¹⁰
May 2, 2023Granted 9,132 shares of Theravance Biopharma, Inc.¹¹
Nov 22, 2022Returned to company 10,000 shares at $10.50 of Theravance Biopharma, Inc.¹²
May 17, 2022Shares withheld for tax 3,168 shares at $38.57 of Perrigo Company Plc¹³
May 17, 2022Exercised options 6,599 shares at $38.57 of Perrigo Company Plc¹³
Apr 26, 2022Granted 9,852 shares of Theravance Biopharma, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.